These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16342674)

  • 1. [Current status and prospect of metabonomics].
    Xu M; Lin DH; Liu CX
    Yao Xue Xue Bao; 2005 Sep; 40(9):769-74. PubMed ID: 16342674
    [No Abstract]   [Full Text] [Related]  

  • 2. Systems biology: Metabonomics.
    Nicholson JK; Lindon JC
    Nature; 2008 Oct; 455(7216):1054-6. PubMed ID: 18948945
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabonomics: systems biology in pharmaceutical research and development.
    Lindon JC; Holmes E; Nicholson JK
    Curr Opin Mol Ther; 2004 Jun; 6(3):265-72. PubMed ID: 15264428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabonomics in toxicology: a review.
    Robertson DG
    Toxicol Sci; 2005 Jun; 85(2):809-22. PubMed ID: 15689416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements.
    Lindon JC; Keun HC; Ebbels TM; Pearce JM; Holmes E; Nicholson JK
    Pharmacogenomics; 2005 Oct; 6(7):691-9. PubMed ID: 16207146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.
    Nicholson JK; Lindon JC; Holmes E
    Xenobiotica; 1999 Nov; 29(11):1181-9. PubMed ID: 10598751
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of metabonomics at the interface between drug metabolism and safety assessment.
    Waters NJ
    Curr Drug Metab; 2010 Oct; 11(8):686-92. PubMed ID: 20973758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.
    Serkova NJ; Niemann CU
    Expert Rev Mol Diagn; 2006 Sep; 6(5):717-31. PubMed ID: 17009906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening, metabolomics and drug discovery.
    Harrigan GG; Yates LA
    IDrugs; 2006 Mar; 9(3):188-92. PubMed ID: 16523384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabonomics in preclinical drug development.
    Robertson DG; Reily MD; Baker JD
    Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):363-76. PubMed ID: 16863449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
    Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool.
    Ala-Korpela M
    Expert Rev Mol Diagn; 2007 Nov; 7(6):761-73. PubMed ID: 18020906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project.
    Lindon JC; Nicholson JK; Holmes E; Antti H; Bollard ME; Keun H; Beckonert O; Ebbels TM; Reily MD; Robertson D; Stevens GJ; Luke P; Breau AP; Cantor GH; Bible RH; Niederhauser U; Senn H; Schlotterbeck G; Sidelmann UG; Laursen SM; Tymiak A; Car BD; Lehman-McKeeman L; Colet JM; Loukaci A; Thomas C
    Toxicol Appl Pharmacol; 2003 Mar; 187(3):137-46. PubMed ID: 12662897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technology insight: metabonomics in gastroenterology-basic principles and potential clinical applications.
    Bjerrum JT; Nielsen OH; Wang YL; Olsen J
    Nat Clin Pract Gastroenterol Hepatol; 2008 Jun; 5(6):332-43. PubMed ID: 18431374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent component analysis-based penalized discriminant method for tumor classification using gene expression data.
    Huang DS; Zheng CH
    Bioinformatics; 2006 Aug; 22(15):1855-62. PubMed ID: 16709589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabonomics techniques and applications to pharmaceutical research & development.
    Lindon JC; Holmes E; Nicholson JK
    Pharm Res; 2006 Jun; 23(6):1075-88. PubMed ID: 16715371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabonomics in pharmaceutical R&D.
    Lindon JC; Holmes E; Nicholson JK
    FEBS J; 2007 Mar; 274(5):1140-51. PubMed ID: 17298438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer biomarkers: a systems approach.
    Hartwell L; Mankoff D; Paulovich A; Ramsey S; Swisher E
    Nat Biotechnol; 2006 Aug; 24(8):905-8. PubMed ID: 16900126
    [No Abstract]   [Full Text] [Related]  

  • 19. Lemna minor L. as a model organism for ecotoxicological studies performing 1H NMR fingerprinting.
    Aliferis KA; Materzok S; Paziotou GN; Chrysayi-Tokousbalides M
    Chemosphere; 2009 Aug; 76(7):967-73. PubMed ID: 19443011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcolemma as model for testing toxicity of chemicals.
    Ali N; Upreti RK; Kidwai AM
    Indian J Biochem Biophys; 1988; 25(1-2):209-14. PubMed ID: 3181979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.